Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance

Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance

<strong>Aims<br></strong> Robust diabetes risk estimates in Asian patients with impaired glucose tolerance (IGT) and coronary heart disease (CHD) are lacking. We developed a Chinese type 2 diabetes risk calculator using Acarbose Cardiovascular Evaluation (ACE) trial data. <br>...

Ամբողջական նկարագրություն

Մատենագիտական մանրամասներ
Հիմնական հեղինակներ:	Xu, S, Scott, CAB, Coleman, RL, Tuomilehto, J, Holman, RR
Ձևաչափ:	Journal article
Լեզու:	English
Հրապարակվել է:	Wiley 2021

Նմանատիպ նյութեր

Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance
‌: Xu, S, և այլն
Հրապարակվել է: (2019)

Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: insights from the Acarbose Cardiovascular Evaluation (ACE) trial
‌: Wamil, M, և այլն
Հրապարակվել է: (2020)

Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): a longitudinal analysis of a randomized, double-blind, placebo-controlled trial
‌: Leal, J, և այլն
Հրապարակվել է: (2022)

People at increased risk of cardiovascular disease screened for the NAVIGATOR trial frequently have undiagnosed diabetes or impaired glucose tolerance
‌: Califf, R, և այլն
Հրապարակվել է: (2003)

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
‌: Currie, G, և այլն
Հրապարակվել է: (2017)

Comparison of medical resources and costs among patients with coronary heart disease and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation trial
‌: Liam Mc Morrow, և այլն
Հրապարակվել է: (2024-02-01)

Impaired glucose tolerance: who and how treats it?
‌: M. N. Mamedov
Հրապարակվել է: (2005-12-01)

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
‌: Holman, R, և այլն
Հրապարակվել է: (2017)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis.
‌: Yates, T, և այլն
Հրապարակվել է: (2014)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): A cohort analysis
‌: Yates, T, և այլն
Հրապարակվել է: (2014)

Increased risk of incident heart failure and death is associated with insulin resistance in people with newly diagnosed type 2 diabetes: UKPDS 89
‌: Wamil, M, և այլն
Հրապարակվել է: (2021)

Perceived Symptoms in People Living with Impaired Glucose Tolerance
‌: Susanne Andersson, և այլն
Հրապարակվել է: (2011-01-01)

Prevalence of Impaired Fasting Glucose and Impaired Glucose Tolerance in Non-Diabetic Patients with Coronary Artery Disease
‌: Nihar Ranjan Mohanty, և այլն
Հրապարակվել է: (2022-06-01)

Increased risk of incident heart failure and all-cause mortality in insulin-resistant people with type 2 diabetes in the United Kingdom Prospective Diabetes Study (UKPDS)
‌: Wamil, M, և այլն
Հրապարակվել է: (2020)

Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease.
‌: Farrer, M, և այլն
Հրապարակվել է: (1993)

Impaired Secretion of Total Glucagon-like Peptide-1 in People with Impaired Fasting Glucose Combined Impaired Glucose Tolerance
‌: Fang Zhang, Xialian Tang, Hongyi Cao, Qingguo Lü, Nali Li, Yupu Liu, Xiangxun Zhang, Yuwei Zhang, Mingming Cao, Jun Wan, Zhenmei An, Nanwei Tong
Հրապարակվել է: (2012-01-01)

Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
‌: Preiss, D, և այլն
Հրապարակվել է: (2013)

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
‌: Califf, R, և այլն
Հրապարակվել է: (2008)

Expert Workshop on Impaired Glucose Tolerance Held in London, UK - 29 March 1995 - Introduction
‌: Holman, R
Հրապարակվել է: (1996)

Effect of Apple Consumption on Postprandial Blood Glucose Levels in Normal Glucose Tolerance People versus Those with Impaired Glucose Tolerance
‌: Yutaka Inoue, և այլն
Հրապարակվել է: (2022-06-01)

'Healthy living' and sulphonylurea therapy have different effects on glucose tolerance and risk factors for vascular disease in subjects with impaired glucose tolerance.
‌: Page, R, և այլն
Հրապարակվել է: (1993)

Variations in the ghrelin receptor gene associate with obesity and glucose metabolism in individuals with impaired glucose tolerance.
‌: Ursula Mager, և այլն
Հրապարակվել է: (2008-08-01)

Relationship between BMI and risk of impaired glucose tolerance and impaired fasting glucose in Chinese adults: a prospective study
‌: Xin Zhang, և այլն
Հրապարակվել է: (2023-01-01)

Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes.
‌: Anke Tönjes, և այլն
Հրապարակվել է: (2010-01-01)

Associations of green tea and rock tea consumption with risk of impaired fasting glucose and impaired glucose tolerance in Chinese men and women.
‌: Huibin Huang, և այլն
Հրապարակվել է: (2013-01-01)

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
‌: Gerstein, H, և այլն
Հրապարակվել է: (2006)

Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial
‌: Preiss, D, և այլն
Հրապարակվել է: (2012)

Resting heart rate and impaired glucose regulation in middle-aged and elderly Chinese people: a cross-sectional analysis
‌: Zhen Yang, և այլն
Հրապարակվել է: (2017-09-01)

International variation in outcomes among people with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the NAVIGATOR Trial.
‌: Dos Santos, M, և այլն
Հրապարակվել է: (2017)

Impaired glucose tolerance in sleep disorders.
‌: Marietta Keckeis, և այլն
Հրապարակվել է: (2010-03-01)

Framingham risk equations underestimate coronary heart disease risk in diabetes.
‌: Stevens, R, և այլն
Հրապարակվել է: (2005)

Metabolic disorders in patients with impaired glucose tolerance, with or without underlying ischaemic heart disease
‌: Brkić Milena, և այլն
Հրապարակվել է: (2022-01-01)

Evidence From a Systematic Review and Meta-Analysis: Classical Impaired Glucose Tolerance Should Be Divided Into Subgroups of Isolated Impaired Glucose Tolerance and Impaired Glucose Tolerance Combined With Impaired Fasting Glucose, According to the Risk of Progression to Diabetes
‌: Yupu Liu, և այլն
Հրապարակվել է: (2022-02-01)

Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with Type 2 diabetes and cardiovascular disease
‌: Mostafa, SA, և այլն
Հրապարակվել է: (2017)

Comparison of medical resources, costs, and health utilities among patients with CHD and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation Trial (ACE)
‌: Mc Morrow, L, և այլն
Հրապարակվել է: (2018)

Impaired Sensitivity to Thyroid Hormones Is Associated With Elevated Blood Glucose in Coronary Heart Disease
‌: Lu Yu, և այլն
Հրապարակվել է: (2022-06-01)

International Variation in Outcomes Among People with Cardiovascular Disease or Cardiovascular Risk Factors and Impaired Glucose Tolerance: Insights from the NAVIGATOR Trial
‌: Marilia Harumi Higuchi dos Santos, և այլն
Հրապարակվել է: (2017-01-01)

List of people who have paid
‌: Cork County Association, CCA

Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
‌: Latini, R, և այլն
Հրապարակվել է: (2013)

Noncardiovascular deaths are more common than cardiovascular deaths in patients with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial.
‌: Sharma, A, և այլն
Հրապարակվել է: (2016)